GHSI: Guardion Health Sciences, Inc. - Summary | Jitta

Guardion Health Sciences, Inc.

NASDAQ:GHSI

Notice
Stock data is unavailable or the company’s delisted.
Price
$3.22
Loss Chance
54.3%
2.29JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (52)
Recent Business Performance (46)
Financial Strength (32)
Return to Shareholders (0)
Competitive Advantage (48)
Jitta Signs
SG&A to SalesDecreasing Every Year
Revenue and EarningEarning loss detected in 2022
Recent Business PerformanceEarning decline 32.36% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
Key Stats
Jitta Score
Jitta Line
2.29
100.00%
4.24
114.58%
Personal Care Products
2.13
36.65%
3.83
221.40%
3.92
29.93%
COMPANY DESCRIPTION
Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.